Other

Unrecognized tax benefits, deferred tax liabilities, gross

Vertex Pharmaceuticals Unrecognized tax benefits, deferred tax liabilities, gross remained flat by 0.0% to $34.63M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 50.7%, from $22.98M to $34.63M. Over 2 years (FY 2023 to FY 2025), Unrecognized tax benefits, deferred tax liabilities, gross shows a downward trend with a -7.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

Higher levels indicate a larger potential tax liability should the company's tax positions be challenged or disallowed by authorities.

Detailed definition

The total gross amount of deferred tax liabilities that are directly linked to unrecognized tax benefits. This represent...

Peer comparison

Standard tax footnote disclosure used to evaluate the scale of potential tax liabilities.

Metric ID: other_unrecognized_tax_benefits_deferred_tax_liabilities_gross

Historical Data

3 years
 FY'23FY'24FY'25
Value$160.00M$91.90M$138.50M
YoY Change-42.6%+50.7%
Range$91.90M$160.00M
CAGR-7.0%
Avg YoY Growth+4.1%
Median YoY Growth+4.1%

Frequently Asked Questions

What is Vertex Pharmaceuticals's unrecognized tax benefits, deferred tax liabilities, gross?
Vertex Pharmaceuticals (VRTX) reported unrecognized tax benefits, deferred tax liabilities, gross of $34.63M in Q4 2025.
How has Vertex Pharmaceuticals's unrecognized tax benefits, deferred tax liabilities, gross changed year-over-year?
Vertex Pharmaceuticals's unrecognized tax benefits, deferred tax liabilities, gross increased by 50.7% year-over-year, from $22.98M to $34.63M.
What is the long-term trend for Vertex Pharmaceuticals's unrecognized tax benefits, deferred tax liabilities, gross?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's unrecognized tax benefits, deferred tax liabilities, gross has grown at a -7.0% compound annual growth rate (CAGR), from $160.00M to $138.50M.
What does unrecognized tax benefits, deferred tax liabilities, gross mean?
The total amount of future tax payments expected from uncertain tax positions.